Cipla reappoints Umang Vohra as MD, Global CEO

Published On 2021-03-24 07:19 GMT   |   Update On 2021-03-24 07:19 GMT

New Delhi: Pharma major Cipla on Tuesday said its board has approved the re-appointment of Umang Vohra as the Managing Director and Global CEO of the company for a further period of five years.The board of directors has considered and approved the re-appointment of Umang Vohra, Managing Director, designated as ''Managing Director and Global Chief Executive Officer'' of the company, for a...

Login or Register to read the full article

New Delhi: Pharma major Cipla on Tuesday said its board has approved the re-appointment of Umang Vohra as the Managing Director and Global CEO of the company for a further period of five years.

The board of directors has considered and approved the re-appointment of Umang Vohra, Managing Director, designated as ''Managing Director and Global Chief Executive Officer'' of the company, for a further period of five years w.e.f. April 1, 2021 to March 31, 2026, Cipla said in a regulatory filing.

Vohra had joined Cipla in 2015 and has been the MD & Global CEO of the company since September 1, 2016, it added.

Read also: Cipla to support Terra Carta, for sustainable future

"As Cipla''s MD & GCEO, Vohra''s priorities have been Cipla''s strategic growth, defining and executing Cipla''s roadmap to maintain momentum in home markets whilst strengthening its presence in other regions, consolidating its core focus areas, augmenting capability, and building the right organisation," the filing said.

After gaining degrees in engineering, marketing and finance, Vohra worked with Eicher Motors, PepsiCo and Dr Reddy''s Laboratories, it added.


Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News